Literature DB >> 15196664

Intratumoral infusion of interleukin-1beta and interferon-gamma induces tumor invasion with macrophages and lymphocytes in a rat glioma model.

Sandra Frewert1, Florian Stockhammer, Guesjal Warschewske, Ana Claudia Zenclussen, Stefan Rupprecht, Hans-Dieter Volk, Christian Woiciechowsky.   

Abstract

Malignant gliomas are hard to treat successfully. Like other treatments immune therapy fails presumably due to low concentration of immune modifiers within the tumor. However, convection-enhanced delivery (CED) may overcome this problem. So, we analyzed the effect of intratumoral delivery of interleukin (IL)-1beta and interferon (IFN)-gamma by CED on tumor immune cell invasion in a rat glioma model. Tumors were implanted into the left caudate nucleus and tumor growth was demonstrated by MRI. Afterwards intratumoral infusion of IL-1beta or IFN-gamma was started for 48 h. Then animals were sacrificed and the number of tumor infiltrating CD4+ and CD8+ lymphocytes as well as macrophages was analyzed by immunohistochemistry. Our results demonstrate that intratumoral cytokine infusion using CED leads to a strong tumor invasion with macrophages and lymphocytes suggesting a tumor specific immune response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196664     DOI: 10.1016/j.neulet.2004.04.037

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

Review 1.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

2.  The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy.

Authors:  Liping Yang; Jingxiang Zhao; Guihong Zhou; Yunfang Wang; Lusi Li; Hongfeng Yuan; Xue Nan; Lidong Guan; Xuetao Pei
Journal:  Neural Regen Res       Date:  2012-06-25       Impact factor: 5.135

Review 3.  Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma.

Authors:  Kirit Singh; Kelly M Hotchkiss; Kisha K Patel; Daniel S Wilkinson; Aditya A Mohan; Sarah L Cook; John H Sampson
Journal:  Cancers (Basel)       Date:  2021-10-26       Impact factor: 6.639

Review 4.  For whom the T cells troll? Bispecific T-cell engagers in glioblastoma.

Authors:  Kirit Singh; Kelly M Hotchkiss; Aditya A Mohan; Jessica L Reedy; John H Sampson; Mustafa Khasraw
Journal:  J Immunother Cancer       Date:  2021-11       Impact factor: 12.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.